Catalyst Pharmaceuticals (CPRX) Non-Current Deffered Revenue (2011 - 2013)

Catalyst Pharmaceuticals (CPRX) has 3 years of Non-Current Deffered Revenue data on file, last reported at $19131.0 in Q4 2013.

• Quarterly Non-Current Deffered Revenue fell 12.56% year-over-year to $19131.0 in Q4 2013, while the trailing twelve-month figure through Dec 2013 was $19131.0 (down 12.56% YoY) and the FY2013 annual result came in at $19131.0, down 12.56% from the prior year.
• Non-Current Deffered Revenue eased to $19131.0 in Q4 2013, from $20040.0 in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $22004.0 in Q2 2012 to a low of $9518.0 in Q4 2011.
• A 3-year average of $19212.7 and a median of $20653.0 in 2013 frame the typical range for Non-Current Deffered Revenue.
• Annual changes were most pronounced in 2012 — Non-Current Deffered Revenue jumped 129.86% — and 2013, when it slipped 12.56%.
• Tracing CPRX's Non-Current Deffered Revenue over 3 years: stood at $9518.0 in 2011, then jumped by 129.86% to $21878.0 in 2012, then declined by 12.56% to $19131.0 in 2013.
• The last three Non-Current Deffered Revenue figures came in at $19131.0 (Q4 2013), $20040.0 (Q3 2013), and $20653.0 (Q2 2013), per Business Quant data.